ProJenX
About:
ProJenX is a biopharmaceutical company that develops novel small molecule therapeutics that target motor neuron degenerative pathways.
Website: https://projenx.com
Top Investors: The ALS Association, Medical Excellence Capital
Description:
ProJenX is a biopharmaceutical company that develops novel small molecule therapeutics that target motor neuron degenerative pathways. The company was founded in 2021 and is headquartered in Nissequogue, New York.
Total Funding Amount:
$21.1M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
New Suffolk, New York, United States
Founded Date:
2021-01-01
Founders:
Erin Fleming
Number of Employees:
1-10
Last Funding Date:
2024-06-20
IPO Status:
Private
Industries:
© 2025 bioDAO.ai